Written question asked by Tanmanjeet Singh Dhesi (Labour) on Wednesday, 15 July 2026, in the House of Commons. It was due for an answer on Wednesday, 2 September 2026 (named day). It was answered by Diana Johnson (Labour) on Wednesday, 2 September 2026 on behalf of the Department of Health and Social Care.
Mefloquine: Veterans
- Question
-
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that clinical assessments for former Armed Forces personnel under (a) Op COURAGE and (b) Op RESTORE include screening for mefloquine (Larium) toxicity.
- Answer
-
NHS England has agreed to include screening for prior mefloquine use as part of patient clinical assessments within Op COURAGE and Op RESTORE. NHS England is working with providers to determine how this information can be recorded within existing clinical systems and reporting structures.
To improve awareness and understanding among general practitioners and across the National Health Service, NHS England is developing information on mefloquine and its potential adverse effects, informed by National Institute for Health and Care Excellence guidance. Once completed, this will be shared across the NHS and made available on the websites of the Royal College of General Practitioners and the National Armed Forces Training and Education Programme.
Secondary information
- Type
- Written question
- Reference
- 19062
- Session
- 2026-27
- Grouped for answer
- Yes
- Subjects
- Screening Veterans Mefloquine
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-02 18:48:09 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/19062
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/19062
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/19062